In cohorts of patients with both ischemic and non-ischemic HFrEF, CHIP is associated with increased risk of HF-death and HF-hospitalization, as well as the development of cardiogenic shock [35, 37]. The gene discussed is STUB1; the disease is hydrops fetalis.